Back
to sessions
Sep 28
Science Highlights
SH 04 - Gastrointestinal Cancer - Science Highlights
session DESCRIPTION
The following abstracts will be highlighted in this session:
- 308 — Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-Line Immunotherapy: A Phase II Clinical Study — Shisuo Du
- 108 — Evaluating Short Course Radiation and ctDNA for Organ Preservation: The Nonoperative Management and Early Response Assessment in Rectal Cancer (NOM-ERA) Trial — Hyun Kim
- 306 — Toripalimab Combined with Radiotherapy vs. Sorafenib in Advanced Hepatocellular Carcinoma with First Branch (Vp3) or Main Trunk (Vp4) Portal Vein Thrombosis: A Prospective, Open-Label, Randomized Trial — Bo Chen
- 107 — Quality of Life and 5-Year Long-Term Organ Preservation in Early Rectal Adenocarcinoma Final Results from the OPERA Trial — Nicolas Barbet
- 292 — Maximal Ablative Irradiation because of Encasement for Patients with Potentially Resectable Locally Advanced Pancreatic Cancer: Final Results of Phase II MAIBE Trial — Marsha Reyngold
Credits
AMA PRA Category 1 Credits: | 0.50 |
CAMPEP Credits: | 0.50 |
Presentations
-
08:00am - 08:30am PT
Discussant
Speaker: Jennifer Wo, MD, FASTRO - Massachusetts General Hospital/ Harvard Medical School, Boston